CSIMarket
 


Pmv Pharmaceuticals Inc   (PMVP)
Other Ticker:  
 

Pmv Pharmaceuticals Inc 's Leverage Ratio

PMVP's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to repayements of liabilities of -4.06% Pmv Pharmaceuticals Inc improved Leverage Ratio in third quarter 2023 to 0.1, above the Pmv Pharmaceuticals Inc 's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the third quarter 2023, 41 other companies have achieved lower Leverage Ratio than Pmv Pharmaceuticals Inc in the III Quarter 2023. While Leverage Ratio total ranking has improved so far in the third quarter 2023 to 104, from total ranking in the second quarter 2023 at 160 .

Explain Leverage Ratio?
Who are PMVP Customers?
What are PMVPīs Total Liabilities?


PMVP Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change -9.03 % -21.36 % -21.13 % -20.27 % -19.62 %
Y / Y Total Liabilities Change -1.58 % 3.45 % 2.69 % 5.52 % 23.72 %
Leverage Ratio MRQ 0.1 0.11 0.1 0.1 0.09
PMVP's Total Ranking # 104 # 160 # 245 # 72 # 207
Seq. Equity Change 9.09 % -5.37 % -6.44 % -5.81 % -5.7 %
Seq. Total Liabilities Change -4.06 % 2.61 % -2.03 % 2.06 % 0.83 %



Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 42
Healthcare Sector # 64
Overall Market # 104


Leverage Ratio Statistics
High Average Low
0.11 0.07 0.01
(Jun 30 2023)   (Sep 30 2020)




Financial Statements
Pmv Pharmaceuticals Inc 's Equity $ 238 Millions Visit PMVP's Balance sheet
Pmv Pharmaceuticals Inc 's Total Liabilities $ 23 Millions Visit PMVP's Balance sheet
Source of PMVP's Sales Visit PMVP's Sales by Geography


Cumulative Pmv Pharmaceuticals Inc 's Leverage Ratio

PMVP's Leverage Ratio for the trailling 12 Months

PMVP Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth -9.03 % -21.36 % -21.13 % -20.27 % -19.62 %
Y / Y Total Liabilities TTM Growth -1.58 % 3.45 % 2.69 % 5.52 % 23.72 %
Leverage Ratio TTM 0.1 0.1 0.09 0.09 0.08
Total Ranking TTM # 157 # 1 # 2 # 1 # 76
Seq. Equity TTM Growth 9.09 % -5.37 % -6.44 % -5.81 % -5.7 %
Seq. Total Liabilities TTM Growth -4.06 % 2.61 % -2.03 % 2.06 % 0.83 %


On the trailing twelve months basis Due to repayements of liabilities of -4.06% Pmv Pharmaceuticals Inc has not changed Leverage Ratio in the 12 months ending in III Quarter 2023 to 0.1, a new company high.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 58, during the past 12 months, other companies have achieved lower Leverage Ratio than Pmv Pharmaceuticals Inc . While Leverage Ratio total ranking has deteriorated during the twelve months ending in the III Quarter 2023, compared to the prior period, from 1 to 157.

Explain Leverage Ratio?
Who are PMVP Customers?
What are PMVPīs Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 59
Healthcare Sector # 87
Within the Market # 157


trailing twelve months Leverage Ratio Statistics
High Average Low
0.1 0.07 0.03
(Sep 30 2023)   (Jun 30 2021)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity
Talphera Inc   0.27 $ 4.954  Millions$ 18.307  Millions
Neurobo Pharmaceuticals Inc   0.27 $ 5.784  Millions$ 21.550  Millions
Imunon Inc   0.27 $ 4.846  Millions$ 18.072  Millions
Cara Therapeutics inc   0.26 $ 22.384  Millions$ 85.642  Millions
Sunshine Biopharma Inc   0.26 $ 5.687  Millions$ 21.963  Millions
Lianbio  0.26 $ 60.564  Millions$ 236.112  Millions
Merus N v   0.25 $ 98.798  Millions$ 393.388  Millions
Edesa Biotech Inc   0.25 $ 1.767  Millions$ 7.049  Millions
Context Therapeutics Inc   0.25 $ 4.604  Millions$ 18.385  Millions
Bellerophon Therapeutics inc  0.25 $ 0.920  Millions$ 3.723  Millions
Savara Inc   0.24 $ 35.528  Millions$ 146.544  Millions
Regeneron Pharmaceuticals Inc   0.24 $ 5,996.300  Millions$ 24,904.400  Millions
Assembly Biosciences Inc   0.24 $ 9.915  Millions$ 41.714  Millions
Erasca Inc   0.24 $ 80.431  Millions$ 338.975  Millions
Deciphera Pharmaceuticals Inc   0.23 $ 89.458  Millions$ 381.670  Millions
Calcimedica Inc   0.23 $ 2.826  Millions$ 12.159  Millions
Renovaro Inc   0.23 $ 10.848  Millions$ 46.746  Millions
Mei Pharma Inc   0.23 $ 18.835  Millions$ 81.361  Millions
Supernus Pharmaceuticals inc   0.23 $ 210.496  Millions$ 912.191  Millions
Lftd Partners Inc   0.23 $ 8.931  Millions$ 38.798  Millions
Praxis Precision Medicines Inc   0.23 $ 19.969  Millions$ 86.756  Millions
Repare Therapeutics Inc   0.23 $ 53.039  Millions$ 233.368  Millions
Adial Pharmaceuticals Inc   0.23 $ 0.528  Millions$ 2.339  Millions
Ainos Inc   0.22 $ 6.179  Millions$ 27.681  Millions
Frequency Therapeutics Inc   0.22 $ 8.185  Millions$ 36.737  Millions
United Therapeutics Corporation  0.22 $ 1,270.900  Millions$ 5,712.100  Millions
Ovid Therapeutics Inc   0.22 $ 22.512  Millions$ 101.292  Millions
Procyon Corporation  0.22 $ 0.568  Millions$ 2.595  Millions
Sanofi  0.22 $ 18,148.480  Millions$ 83,275.360  Millions
Zentalis Pharmaceuticals Inc   0.22 $ 103.947  Millions$ 481.897  Millions

Date modified: 2023-11-12T12:42:27+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Đ 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com